Geneos Wealth Management’s Comerica CMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-600
| Closed | -$52.2K | – | 2486 |
|
|
2025
Q4 | $52.2K | Hold |
600
| – | – | ﹤0.01% | 1374 |
|
|
2025
Q3 | $41.1K | Sell |
600
-91
| -13% | -$6.13K | ﹤0.01% | 1453 |
|
|
2025
Q2 | $41.2K | Sell |
691
-1,032
| -60% | -$57.6K | ﹤0.01% | 1684 |
|
|
2025
Q1 | $102K | Buy |
1,723
+1,302
| +309% | +$81.8K | ﹤0.01% | 1563 |
|
|
2024
Q4 | $26K | Buy |
421
+117
| +38% | +$7.61K | ﹤0.01% | 1600 |
|
|
2024
Q3 | $18.2K | Buy |
304
+4
| +1% | +$221 | ﹤0.01% | 1592 |
|
|
2024
Q2 | $15.3K | Hold |
300
| – | – | ﹤0.01% | 1425 |
|
|
2024
Q1 | $16.5K | Sell |
300
-400
| -57% | -$20.9K | ﹤0.01% | 1423 |
|
|
2023
Q4 | $39.1K | Hold |
700
| – | – | ﹤0.01% | 1143 |
|
|
2023
Q3 | $29.1K | Hold |
700
| – | – | ﹤0.01% | 1252 |
|
|
2023
Q2 | $29.7K | Buy |
700
+200
| +40% | +$8.08K | ﹤0.01% | 1250 |
|
|
2023
Q1 | $21.7K | Hold |
500
| – | – | ﹤0.01% | 1321 |
|
|
2022
Q4 | $33.4K | Hold |
500
| – | – | ﹤0.01% | 1188 |
|
|
2022
Q3 | $35K | Sell |
500
-20
| -4% | -$1.58K | ﹤0.01% | 1141 |
|
|
2022
Q2 | $38K | Hold |
520
| – | – | ﹤0.01% | 1393 |
|
|
2022
Q1 | $47K | Hold |
520
| – | – | ﹤0.01% | 1413 |
|
|
2021
Q4 | $45K | Hold |
520
| – | – | ﹤0.01% | 1521 |
|
|
2021
Q3 | $42K | Hold |
520
| – | – | ﹤0.01% | 1565 |
|
|
2021
Q2 | $37K | Sell |
520
-105
| -17% | -$7.78K | ﹤0.01% | 1622 |
|
|
2021
Q1 | $46K | Buy |
625
+45
| +8% | +$2.95K | ﹤0.01% | 1675 |
|
|
2020
Q4 | $1K | Buy |
+580
| New | +$28.3K | ﹤0.01% | 2771 |
|
|
2020
Q1 | – | Sell |
-20
| Closed | -$1K | – | 2495 |
|
|
2019
Q4 | $1K | Hold |
20
| – | – | ﹤0.01% | 2447 |
|
|
2019
Q3 | $1K | Sell |
20
-130
| -87% | -$8.61K | ﹤0.01% | 2379 |
|
|
2019
Q2 | $10K | Hold |
150
| – | – | ﹤0.01% | 1895 |
|
|
2019
Q1 | $10K | Hold |
150
| – | – | ﹤0.01% | 1831 |
|
|
2018
Q4 | $10K | Buy |
150
+130
| +650% | +$10.3K | ﹤0.01% | 1774 |
|
|
2018
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 2326 |
|
|
2018
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 2171 |
|
|
2018
Q1 | $1K | Hold |
20
| – | – | ﹤0.01% | 2088 |
|
|
2017
Q4 | $1K | Hold |
20
| – | – | ﹤0.01% | 2084 |
|
|
2017
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 2028 |
|
|
2017
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 1983 |
|
|
2017
Q1 | $1K | Hold |
20
| – | – | ﹤0.01% | 1965 |
|
|
2016
Q4 | $1K | Buy |
+20
| New | +$1.17K | ﹤0.01% | 1932 |
|
Other funds holding CMA
KRS
CC
IA
HNB
Geneos Wealth Management's CMA Position: Q1 2026 in Review
Geneos Wealth Management sold out of Comerica (CMA) in Q1 2026, closing a stake of 600 shares — an estimated $52.2K sold.
Geneos Wealth Management first reported a position in CMA in Q4 2016 and held it in 34 quarters. The position peaked at $102K in Q1 2025. 4 funds tracked by Wall St. Rank hold CMA as of Q1 2026.
- Geneos Wealth Management reported no remaining Comerica position as of Q1 2026 after selling out during the quarter.
- Geneos Wealth Management sold 600 Comerica shares in Q1 2026, an estimated $52.2K.
- Geneos Wealth Management first reported a position in Comerica in Q4 2016 and held it in 34 quarters.
- Geneos Wealth Management's Comerica position peaked at $102K in Q1 2025.
- 4 funds tracked by Wall St. Rank held Comerica as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.